Dramatic response to brigatinib in a lung adenocarcinoma patient harboring EML4-ALK fusion and a G1202R de novo gene mutation.
作者信息
Pan Yue, Zeng Yue, Peng Yurong, Liu Xiaohan, Li Yizheng, Wu Fang
机构信息
Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China; Human Cancer Mega-Data Intelligent Application and Engineering Research Centre, Changsha, 410011, Hunan, China; Human Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China; Human Key Laboratory of Early Diagnosis and Precision Therapy in Lung Cancer, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
出版信息
Eur J Cancer. 2022 Apr;165:154-156. doi: 10.1016/j.ejca.2022.02.001. Epub 2022 Feb 27.
Zotero 插件